A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2)

by Liu, J.-Y, Wang, H.-X, Xu, P.-P, Yu, W.-D, Zeng, M.-S
Published 2021

Alcohol Increases Lung Angiotensin-Converting Enzyme 2 Expression and Exacerbates Severe Acute...

by Catravas, J.D, Colunga Biancatelli, R.M.L, Solopov, P.A
Published 2022

SARS-CoV-2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms

by Adcock, M., Anderson, S., Bordin, N., Dallago, C., Ho, B.K, Kaur, S., O’Donoghue, S.I, Procter, J.B, Rost, B., Schafferhans, A., Sikta, N., Stolte, C.
Published 2021

Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2

by Ahmad, M., Bhattacharyya, S., Biswal, B.K, Chakraborty, S., Dwivedy, A., Jeyakanthan, J., Kar, D., Majumdar, T., Mani, S., Mariadasse, R., Sonar, S., Tailor, P., Tiwari, S.
Published 2021

Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2

by Abdullah-Al-Mamun, M., Ahammad, F., Alam, R., Bouback, T.A, Hossen, M.S, Imon, R.R, Karpiński, T.M, Nain, Z., Nur, S.M, Pokhrel, S., Qadri, I., Rahman, M.S, Samad, A., Talukder, M.E.K, Tareq, M.M.I
Published 2021

Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection

by Gao, X., Huang, H., Ma, C., Peng, H., Ren, H., Su, Y., Zhang, B., Zhou, L.
Published 2021

Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants

by Adolf-Bryfogle, J., Cha, J.S, Cho, H.-S, Coventry, B., Hwang, I., Jeong, B.-S, Kim, K.-D, Kim, U., Oh, B.-H
Published 2022

Molecular Dynamics and MM-PBSA Analysis of the SARS-CoV-2 Gamma Variant in Complex with the hACE-2 Receptor

by Arciniega, M., Cavani, M., Riofrío, W.A
Published 2022

Molecular Dynamics and MM-PBSA Analysis of the SARS-CoV-2 Gamma Variant in Complex with the hACE-2 Receptor

by Arciniega, M., Cavani, M., Riofrío, W.A
Published 2022

Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants

by Gowthaman, R., Guest, J.D, Mittra, I., Pierce, B.G, Quackenbush, J., Taherzadeh, G., Yin, R.
Published 2021

Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives

by Karakaş, N., Karaoğlan, B.S, Öztürk, G., Shah, K., Üçüncüoğlu, S., Uludağ, D.
Published 2022

Genome-scale CRISPR screens identify host factors that promote human coronavirus infection

by Bluhm, A.P, Grodzki, M., Karst, S.M, Norris, M.H, Rafiee, R., Russo, M., Schaefer, M., Sobh, A., Tagmount, A., Vulpe, C.D
Published 2022

The atlas of ACE2 expression in fetal and adult human hearts reveals the potential mechanism of heart-injured patients infected with SARS-CoV-2

by Feng, R., Hao, L., Hou, X., Shao, X., Wu, F., Yi, W., Zhang, R., Zhang, X., Zhu, R.
Published 2022

Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2

by Alsaadawe, M., Chen, X., Chen, Z., Disoma, C., Dong, Z., Du, A., Hu, L., Jiang, T., Li, S., Li, S., Li, S., Liu, P., Liu, S., Mo, L., Peng, J., Peng, Y., Razzaq, A., Shen, Y., Xia, Z., Yang, Q., Zhang, Q., Zhang, Y., Zheng, R., Zhou, Y.
Published 2021

Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression

by Balasuriya, U.B.R, Bosmann, M., Carossino, M., Crossland, N.A, Douam, F., Ericsson, M., Francis, K.P, Gertje, H.P, Grosz, K.A, Huber, B.R, Kenney, D., Kirkland, T.A, Klose, A.D, Kurnick, S.A, Montanaro, P., O’connell, A.K, Paragas, N., Saeed, M., Subramaniam, S., Tseng, A.E, Walker, J.R
Published 2022